Synthetic high-density lipoprotein nanoparticles delivering rapamycin for the treatment of age-related macular degeneration.

No abstract is available for this paper.

• Publication year

  2022

• Venue

  Nanomedicine : nanotechnology, biology, and medicine

• Publication date

  2022-05-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.nano.2022.102571PMID 35623563PMCID PMC10655893
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Small molecule activation of metabolic enzyme pyruvate kinase muscle isozyme 2, PKM2, circumvents photoreceptor apoptosis

  2020cited by this paper
• Synthetic high-density lipoproteins delivering liver X receptor agonist prevent atherogenesis by enhancing reverse cholesterol transport.

  2020cited by this paper
• Autophagy Dysfunction, Cellular Senescence, and Abnormal Immune-Inflammatory Responses in AMD: From Mechanisms to Therapeutic Potential

  2019cited by this paper
• The impact of lipids, lipid oxidation, and inflammation on AMD, and the potential role of miRNAs on lipid metabolism in the RPE

  2019cited by this paper
• Understanding AMD by analogy: systematic review of lipid-related common pathogenic mechanisms in AMD, AD, AS and GN

  2018cited by this paper
• RPE phagocytic function declines in age-related macular degeneration and is rescued by human umbilical tissue derived cells

  2018cited by this paper
• Impaired monocyte cholesterol clearance initiates age-related retinal degeneration and vision loss.

  2018cited by this paper
• Directional ABCA1-mediated cholesterol efflux and apoB-lipoprotein secretion in the retinal pigment epithelium

  2018cited by this paper
• ApoA-I Mimetic Peptide 4F Reduces Age-Related Lipid Deposition in Murine Bruch’s Membrane and Causes Its Structural Remodeling

  2018cited by this paper
• Development of CER-001: Preclinical Dose Selection Through to Phase I Clinical Findings

  2017cited by this paper
• High‐density lipoprotein mutant eye drops for the treatment of posterior eye diseases

  2017cited by this paper
• Synthetic High-Density Lipoprotein-Mediated Targeted Delivery of Liver X Receptors Agonist Promotes Atherosclerosis Regression

  2017cited by this paper
• Inhibition or Stimulation of Autophagy Affects Early Formation of Lipofuscin-Like Autofluorescence in the Retinal Pigment Epithelium Cell

  2017cited by this paper
• Regulated efflux of photoreceptor outer segment‐derived cholesterol by human RPE cells

  2017cited by this paper
• Preformulation Studies of a Liposomal Formulation Containing Sirolimus for the Treatment of Dry Eye Disease

  2016cited by this paper
• The Neuroprotective Effect of Rapamycin as a Modulator of the mTOR-NF-κB Axis during Retinal Inflammation

  2016cited by this paper
• Synthetic high-density lipoproteins for delivery of 10-hydroxycamptothecin

  2016cited by this paper
• Designer vaccine nanodiscs for personalized cancer immunotherapy

  2016cited by this paper
• Retinal Toxicity of Intravitreal Polyethylene Glycol 400

  2016cited by this paper
• Intravitreal injection of rapamycin-loaded polymeric micelles for inhibition of ocular inflammation in rat model.

  2016cited by this paper
• High-Density Lipoproteins: Nature's Multifunctional Nanoparticles.

  2016cited by this paper
• Protective effect of autophagy on human retinal pigment epithelial cells against lipofuscin fluorophore A2E: implications for age-related macular degeneration

  2015cited by this paper
• The effect of phospholipid composition of reconstituted HDL on its cholesterol efflux and anti-inflammatory properties[S]

  2015cited by this paper
• Rapamycin: one drug, many effects.

  2014cited by this paper
• Nanomicellar Topical Aqueous Drop Formulation of Rapamycin for Back-of-the-Eye Delivery

  2014cited by this paper
• Unexpected low‐dose toxicity of the universal solvent DMSO

  2014cited by this paper
• Cholesterol in the retina: the best is yet to come.

  2014cited by this paper
• Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis.

  2014cited by this paper
• Dysregulated autophagy in the RPE is associated with increased susceptibility to oxidative stress and AMD

  2014cited by this paper
• Eyeballing cholesterol efflux and macrophage function in disease pathogenesis.

  2014cited by this paper
• High density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular disease1

  2013cited by this paper
• Autophagy and heterophagy dysregulation leads to retinal pigment epithelium dysfunction and development of age-related macular degeneration

  2013cited by this paper
• High density lipoprotein mediates anti-inflammatory transcriptional reprogramming of macrophages via the transcriptional repressor ATF3

  2013cited by this paper
• Nanoparticle diffusion in, and microrheology of, the bovine vitreous ex vivo.

  2013cited by this paper
• Autophagy in the retina: a potential role in age-related macular degeneration.

  2012cited by this paper
• Inflammaging: disturbed interplay between autophagy and inflammasomes

  2012cited by this paper
• Rapamycin slows aging in mice

  2012cited by this paper
• Age related macular degeneration and drusen: neuroinflammation in the retina.

  2011cited by this paper
• The influence of co-solvents on the stability and bioavailability of rapamycin formulated in self-microemulsifying drug delivery systems

  2011cited by this paper
• Autophagy promotes survival of retinal ganglion cells after optic nerve axotomy in mice

  2011cited by this paper
• Mechanisms of protein aggregation in the retinal pigment epithelial cells.

  2010cited by this paper
• Macrophage ABCA1 reduces MyD88-dependent Toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol[S]

  2010cited by this paper
• Rapamycin protects against rotenone-induced apoptosis through autophagy induction.

  2009cited by this paper
• mTOR's role in ageing: protein synthesis or autophagy?

  2009cited by this paper
• Review: Autophagy in neurodegeneration: firefighter and/or incendiarist?

  2009cited by this paper
• Rapamycin decelerates cellular senescence

  2009cited by this paper
• How to Interpret LC3 Immunoblotting

  2007cited by this paper
• Role of autophagy in cancer

  2007cited by this paper
• Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial.

  2007cited by this paper
• Age-related macular degeneration (AMD): pathogenesis and therapy.

  2006cited by this paper
• The retinal pigment epithelium in visual function.

  2005cited by this paper
• Rapamycin attenuates vascular wall inflammation and progenitor cell promoters after angioplasty

  2005cited by this paper
• Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial.

  2003cited by this paper
• Suppression of Endothelial Cell Apoptosis by High Density Lipoproteins (HDL) and HDL-associated Lysosphingolipids*

  2001cited by this paper
• Effect of Particle Size of Polymeric Nanospheres on Intravitreal Kinetics

  2000cited by this paper
• The retinal pigment epithelium: a versatile partner in vision

  1993cited by this paper

• Advances in nanomedicine-based retinal drug delivery: mechanisms and translational applications

  2025cites this paper
• Utilization of Nanoparticles for Treating Age-Related Macular Degeneration

  2025cites this paper
• Mechanisms and Applications of Apolipoproteins and Apolipoprotein Mimetic Peptides: Common Pathways in Cardiovascular Disease and Cancer.

  2025cites this paper
• Targeting Lysosomal Dysfunction and Oxidative Stress in Age-Related Macular Degeneration

  2025cites this paper
• Development of rapamycin-loaded PLGA nanoparticles for treating retinopathy of prematurity.

  2025cites this paper
• Retinal Autophagy for Sustaining Retinal Integrity as a Proof of Concept for Age-Related Macular Degeneration

  2025cites this paper
• Advances in materials science for ocular diseases induced by cardiovascular risk factors

  2025cites this paper
• Drug Delivery Technologies for the Treatment of Age‐Related Macular Degeneration

  2025cites this paper
• Trojan Horse‐Inspired Biomimetic Lipoprotein Nanocarrier for Noninvasive Anti‐VEGF Therapy of Ocular Fundus Neovascularization

  2025cites this paper
• Self-assembled rapamycin prodrug nanoparticles for posterior segment targeting and effective treatment of experimental uveitis.

  2025cites this paper
• Cognitive Improvement Effects of Polymer-Based Microencapsulated Celecoxib in a Rat Model of Alzheimer’s Disease

  2024cites this paper
• A Sustainable Retinal Drug Co‐Delivery for Boosting Therapeutic Efficacy in wAMD: Unveiling Multifaceted Evidence and Synergistic Mechanisms

  2024cites this paper
• Autophagy in dry AMD: a promising therapeutic strategy for retinal pigment epithelial cell damage.

  2024cites this paper
• Intravitreal therapeutic nanoparticles for age-related macular degeneration: Design principles, progress and opportunities.

  2024cites this paper
• The Impact of NF-κB on Inflammatory and Angiogenic Processes in Age-Related Macular Degeneration.

  2024cites this paper
• Nanomaterials in the diagnosis and treatment of ophthalmic diseases

  2024cites this paper
• Overcoming Treatment Challenges in Posterior Segment Diseases with Biodegradable Nano-Based Drug Delivery Systems

  2023cites this paper
• Curcumin as a Perspective Protection for Retinal Pigment Epithelium during Autophagy Inhibition in the Course of Retinal Degeneration

  2023cites this paper
• Lipofuscin, Its Origin, Properties, and Contribution to Retinal Fluorescence as a Potential Biomarker of Oxidative Damage to the Retina

  2023cites this paper
• Ocular barriers as a double-edged sword: preventing and facilitating drug delivery to the retina

  2022cites this paper